medigraphic.com

2017, Number 1

<< Back Next >>

Rev Hosp Jua Mex 2017; 84 (1)

Nutritional alterations in patients with neurological diseases

Pérez-Cruz E, Barrientos-Jiménez M, Camacho-Guerra CD, Tapia-Gómez Y, Torres-González KO, Uribe-Quiroz G

Language: Spanish
References: 53
Page: 26-36
PDF size: 233.93 Kb.


ABSTRACT

Neurological diseases, both acute and chronic, have become one of the major health problems due to the increase of trauma patients, cerebrovascular diseases and dementia. An adequate nutritional therapy is essential for the recovery of neurological patients. The evaluation and nutritional requirements are different for each disease and depend on the clinical characteristics and the patient’s possibilities. The current article reviews the most relevant nutritional aspects of neurological care patients.


REFERENCES

  1. DeLegge MH, Smoke A. Neurodegeneration and inflammation. Nutr Clin Pract 2008; 23(1): 35-41.

  2. Planas-Vilà M. Aspectos metabólico-nutricionales en las enfermedades neurológicas. Nutr Hosp 2014; 29(Supl. 2): 3-12.

  3. Foley N, Marshall S, Pikul J, Salter K, Teasell R. Hypermetabolism following moderated to severe traumatic acute brain injury: a systematic review. J Neurotrauma 2008; 25(12): 1415-31.

  4. Thibault-Halman G, Casha S, Singer S, Christie S. Acute management of nutritional demands after spinal cord injury. J Neurotrauma 2011; 28(8): 1497-507.

  5. Saka B, Kaya O, Ozturk GB, Erten N, Karan MA. Malnutrition in the elderly and its relationship with other geriatric syndromes. Clin Nutr 2010; 29(6): 745-8.

  6. Bachmann CG, Trenkwalder C. Body weight in patients with Parkinson’s disease. Mov Disord 2006; 21(11): 1824-30.

  7. Poehlman ET, Dvorak RV. Energy expenditure, energy intake, and weight loss in Alzheimer disease. Am J Clin Nutr 2000; 71(2): 650S-5S.

  8. Palma JA, Kaufmann H. Autonomic disorders predicting Parkinson’s disease. Parkinsonism Relat Disord 2014; 20 Suppl 1: S94-8.

  9. Smith HA, Kindell J, Baldwin RC, Waterman D, Makin AJ. Swallowing problems and dementia in acute hospital settings: practical guidance for the management of dysphagia. Clin Med (Lond) 2009; 9(6): 544-8.

  10. Martínez-Vila E. Investigación de enfermedades neurológicas en España. Documento de consenso sobre estrategias y prioridades. Madrid: Sociedad Española de Neurología; 2010. p. 39-99.

  11. Breton I, Burgos R, Planas M. Nutrición en las enfermedades neurológicas. En: Tratado de nutrición. 2a edición. Madrid: Ed A Gil, Panamericana; 2010.

  12. De Azevedo-Fernandez R, Corrêa C, Muxfeld-Bianchim M, Schweigert-Perry ID. Anthropometric profile and nutritional intake in patients with epilepsy. Nutr Hosp 2015; 32(2): 817-22.

  13. Bertoli S, Cardinali S, Veggiotti P, Trentani C, Testolin G, Tagliabue A. Evaluation of nutritional status in children with refractory epilepsy. Nutr J 2006; 5: 14.

  14. Volkert D, Chourdakis M, Faxen-Irving G, Frühwald T, Landi F, Suominen MH, et al. ESPEN guidelines on nutrition in dementia. Clin Nutr 2015; 34(6): 1052-73.

  15. Sebastian S, Nair PG, Thomas P, Tyagi AK. Oropharyngeal dysphagia: neurogenic etiology and manifestation. Indian J Otolaryngol Head Neck Surg 2015; 67(Suppl 1): 119-23.

  16. Pasquinelli S, Solaro C. Nutritional assessment and malnutrition in multiple sclerosis. Neurol Sci 2008; 29 Suppl 4: S367-9.

  17. Habek M, Hojsak I, Brinar VV. Nutrition in multiple sclerosis. Clin Neurol Neurosurg 2010; 112(7): 616-20.

  18. Bretón-Lesmes I, Burgos-Peláez R, Cuerda C, Camblor M, Velasco C, Higuera I, et al. Nutritional support in chronic neurological diseases. Nutr Hosp 2014; 29 Suppl 2: 38-46.

  19. Saka M, Saka M, Koseler E, Metin S, Bilen S, Aslanyavrusu M, et al. Nutritional status and anthropometric measurements of patients with multiple sclerosis. Saudi Med J 2012; 33(2): 160-6.

  20. Vandewoude M, Van Gossum A. Nutritional screening strategy in nonagenarians: the value of the MNA-SF (mini nutritional assessment short form) in NutriAction. J Nutr Health Aging 2013; 17(4): 310-4.

  21. Chapman IM. Weight loss in older persons. Med Clin North Am 2011; 95(3): 579-93.

  22. Phillips MB, Foley AL, Barnard R, Isenring EA, Miller MD. Nutritional screening in community-dwelling older adults: a systematic literature review. Asia Pac J Clin Nutr 2010; 19(3): 440-9.

  23. Van Bokhorst-de van der Schueren MA, Guaitoli PR, Jansma EP, de Vet HC. Nutrition screening tools: does one size fit all? A systematic review of screening tools for the hospital setting. Clin Nutr 2014; 33(1): 39-58.

  24. Morley JE. Nutrition and the brain. Clin Geriatr Med 2010; 26(1): 89-98.

  25. Alagiakrishnan K, Bhanji RA, Kurian M. Evaluation and management of oropharyngeal dysphagia in different types of dementia: a systematic review. Arch Gerontol Geriatr 2013; 56(1): 1-9.

  26. John JS, Berger L. Using the gugging swallowing screen (GUSS) for dysphagia screening in acute stroke patients. J Contin Educ Nurs 2015; 46(3): 103-4.

  27. Etges CL, Scheeren B, Gomes E, Barbosa L de R. Screening tools for dysphagia: a systematic review. Codas 2014; 26(5): 343-9.

  28. Hurt RT, McClave SA. Nutritional assessment in primary care. Med Clin North Am 2016; 100(6): 1169-83.

  29. Ponce de León GP, Mayagoitia-Witrón JJ, Cornejo-Bravo JM, Pérez- Morales ME. Nutrición enteral en el paciente con traumatismo cráneo encefálico: revisión sistemática de ensayos clínicos. Revista Iberoamericana de Ciencias de la Salud 2015; 4(7): 1-17.

  30. Casaubon LK, Boulanger JM, Glasser E, Blacquiere D, Boucher S, Brown K, et al. Canadian stroke best practice recommendations: acute inpatient stroke care guidelines, update 2015. Int J Stroke 2016; 11(2): 239-52.

  31. Sánchez-Álvarez C, Vigil-Velis M, Barraza-Aguirre E, Hernández- Serrano JM, Martínez-Lozano Aranaga F. Nutritional support in the neurocritical patient. Nutr Hosp 2014; 29 Suppl 2: 22-31.

  32. Baena-González M, Molina-Recio G. Abordaje de la disfagia en enfermos de Alzhéimer. Nutr Hosp 2016; 33(3): 286.

  33. Marina B, Beghi E, Vial C, Bernard E, Lautrette G, Clavelou P, et al. EURECALS consortium. Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres. Eur J Neurol 2016; 23(4): 787-95.

  34. Nieves JW, Gennings C, Factor-Litvak P, Hupf J, Singleton J, Sharf V, et al. Association between dietary intake and function in amyotrophic lateral sclerosis. JAMA Neurol 2016; 73(12): 1425-32.

  35. Silva P, Kergoat MJ, Shatenstein B. Challenges in managing the diet of older adults with early-stage Alzheimer dementia: a caregiver perspective. J Nutr Health Aging 2013; 17(2): 142-7.

  36. Song C, Shieh CH, Wu KS, Kalueff A, Gaikwad S, Su KP. The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer’s disease: Acting separately of synergistically? Prog Lipid Res 2016; 62: 41-54.

  37. Ramesh BN, Rao TS, Prakasam A, Sambamurti K, Rao KS. Neuronutrition and Alzheimer’s disease. J Alzheimers Dis 2010; 19(4): 1123-39.

  38. Gillette-Guyonnet S, Abellan Van Kan G, Alix E, Andrieu S, Belmin J, Berrut G, et al. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer’s disease. J Nutr Health Aging 2007; 11(1): 38-48.

  39. Greenwood CE, Parrott MD. Nutrition as a component of dementia risk reduction strategies. Healthcare Manag Forum 2017; 30(1): 40-5.

  40. Davoodi J, Markert CD, Voelker KA, Hutson SM, Grange RW. Nutrition strategies to improve physical capabilities in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am 2012; 23(1): 187-99.

  41. Ellwanger JH, Franke SI, Bordin DL, Prá D, Henriques JA. Biological functions of selenium and its potential influence on Parkinson’s disease. An Acad Bras Ciênc 2016; 88(3 Suppl): 1655-74.

  42. Murakami K, Miyake Y, Sasaki S, Tanaka K, Fukushima W, Kiyohara C, et al. Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson’s disease: a case-control study in Japan. Br J Nutr 2010; 104(5): 757-64.

  43. Marcason W. What are the primary nutritional issues for a patient with Parkinson’s disease? J Am Diet Assoc 2009; 109(7): 1316.

  44. McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). JPEN J Parenter Enteral Nutr 2016; 40(2): 159-211.

  45. Heyland DK. Should we PERMIT systematic underfeeding in all intensive care unit patients? Integrating the results of the PERMIT study in our clinical practice guidelines. JPEN J Parenter Enteral Nutr 2016; 40(2): 156-8.

  46. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 2009; 28(4): 387-400.

  47. Hoffer LJ, Bistrian BR. Nutrition in critical illness: a current conundrum. F1000Res. 2016; 5: 2531.

  48. Adebamowo SN, Spiegelman D, Willett WC, Rexrode KM. Association between intakes of magnesium, potassium, and calcium and risk of stroke: 2 cohorts of US women and updated metaanalyses. Am J Clin Nutr 2015; 101(6): 1269-77.

  49. Alwan A. Global status report on non-communicable diseases 2010. Geneva: World Health Organization; 2011.

  50. Nutrición parenteral: prevención de las complicaciones metabólicas, orgánicas y relacionadas a las mezclas de nutrición parenteral. México: Secretaría de Salud; 2012.

  51. Nutrición enteral: fórmulas, métodos de infusión e interacción fármaco-nutriente. México: Secretaría de Salud; 2012.

  52. Ballesteros PM, Arés LA, Vidal AC, Calleja FA, Cano RI. Interacción entre dieta y fármacos. En: De Luis Román DA, editores. Dietoterapia, nutrición clínica y metabolismo. Madrid: Ediciones Díaz de Santos; 2012. p. 631-40.

  53. Piñeiro-Corrales G. Interacción fármaco-nutriente en patología neurológica. Nutr Hosp Suplementos 2009; 2(2): 89-105.




2020     |     www.medigraphic.com